PMGC Holdings Inc. (NASDAQ:ELAB) Short Interest Update

PMGC Holdings Inc. (NASDAQ:ELAB) was the recipient of a large drop in short interest in April. As of April 30th, there was short interest totaling 236,186 shares, a drop of 43.0% from the April 15th total of 414,506 shares. Based on an average daily volume of 1,987,934 shares, the days-to-cover ratio is currently 0.1 days. Currently, 20.4% of the company’s stock are sold short.

PMGC Stock Down 8.2%

Shares of PMGC stock traded down $0.17 during trading on Monday, reaching $1.91. The company had a trading volume of 297,010 shares, compared to its average volume of 5,059,314. The company has a market cap of $2.22 million, a price-to-earnings ratio of 0.00 and a beta of -0.27. The firm’s fifty day moving average is $3.70 and its 200-day moving average is $41.16. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.72 and a current ratio of 1.74. PMGC has a fifty-two week low of $1.62 and a fifty-two week high of $309.12.

PMGC (NASDAQ:ELAB) last issued its earnings results on Thursday, May 14th. The company reported ($11.22) earnings per share (EPS) for the quarter. The firm had revenue of $0.68 million for the quarter.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.